[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:
29-Jan-2014

[ | E-mail ] Share Share

Contact: Mareille Prevo
m.prevo@elsevier.com
31-204-853-783
Elsevier

Elsevier announces the launch of open access journal: Pathogenesis

OA journal Pathogenesis published on behalf of The Royal College of Pathologists

Oxford, January 29, 2014 -- Elsevier, world-leading provider of scientific, technical and medical information products and services, announces the launch of open access journal, Pathogenesis.

Pathogenesis will be published on behalf of The Royal College of Pathologists a professional membership organization committed to setting and maintaining professional standards and promoting excellence in the practice of Pathology. The College represents 19 pathology specialties and has over 10,000 members working in hospital laboratories, universities and industry, worldwide.

Pathogenesis will provide a home for research covering all areas of illness and normal cellular and molecular development in human and veterinary disease. The journal Pathogenesis will publish peer reviewed original scientific research articles and high quality reviews, editorials and letters to the editor which report on multidisciplinary areas of Molecular and Diagnostic Pathology, Cellular Mechanisms as well as aspects of Haematology, Proteomics, Virology, Microbiology and Chemical Pathology.

The Editor-in-Chief of the journal, Professor Finbarr Cotter, Barts Cancer Institute, Queen Mary University of London, UK said of the launch, "This is a tremendous cooperation between The Royal College of Pathologists and Elsevier, one which confirms the major commitment by the College towards the modernization of the field of pathology with both academic and molecular pathology leading the way."

Professor Cotter will work closely with Section Editors: Professor Ian Cree University Hospital Coventry and Warwickshire, UK and Dr George Vassilou, Wellcome Trust Sanger Institute, Cambridge, UK.

"We are delighted to announce the launch of this new open access journal. We look forward to working together with the journal editors and The Royal College of Pathologists offering their members, researchers and clinicians a platform through which they can publish their research quickly and make it widely available," said Rachel Garland, Publisher at Elsevier.

###

For more information or to submit an article, go to: http://www.pathogenesisjournal.com/

About Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as 82 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact

Mareille Prevo
Elsevier
+31 20 485 3783
m.prevo@elsevier.com



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.